10x Genomics Inc

$163.56 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About 10x Genomics Inc

10x Genomics, Inc. is a life science technology company. The Company’s integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. The Company’s product consists of chromium single cell gene expression solution, cell immune profiling solution, cell copy number variation (CNV) solution, Cell assay for transposase accessible chromatin (ATAC) solution. The Company’s Chromium platform enables analysis of individual biological components, such as up to millions of single cells. Its Visium platform is designed to identify where biological components are located and how they are arranged with respect to each other. Its molecular assays are used with its Chromium platform, and with its planned Visium platform, to provide sensitive and robust biochemistries that convert minute amounts of biological analytes into detectable signals.

Stock Analysis

last close $164.03
1-mo return 3.3%
3-mo return -11.8%
avg daily vol. 576.11T
52-week high 208.99
52-week low 125.84
market cap. $13.8B
forward pe -
annual div. -
roe -85.7%
ltg forecast -
dividend yield -
annual rev. $406M
inst own. 89.9%

Subscribe now for daily local and international financial news